USA - NASDAQ:CVET - US22304C1009 - Common Stock
The current stock price of CVET is 20.99 USD. In the past month the price increased by 0.53%. In the past year, price increased by 5.58%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 23.77 | 107.23B | ||
| COR | CENCORA INC | 22.55 | 69.92B | ||
| CAH | CARDINAL HEALTH INC | 23.37 | 49.47B | ||
| HSIC | HENRY SCHEIN INC | 14.7 | 8.59B | ||
| AHCO | ADAPTHEALTH CORP | 28.19 | 1.22B | ||
| OMI | OWENS & MINOR INC | 2.19 | 217.82M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 51.30M |
Covetrus, Inc. is an animal-health technology and services company, which serves animal veterinary markets. The Company operates through three segments. North America segment offers supply chain services, software services and prescription management to its customers and animal-owners. Europe segment offers supply chain services and software services to its customers and animal-owners. Asia-Pacific & Emerging Markets segment offers supply chain services and software services to its customers and animal-owners. The Company's products and services include supply chain services, software services, and prescription management. It offers a comprehensive portfolio of products, services and value-added solutions for enhancing delivering animal care. It develops, provides and supports veterinary practices with a range of veterinary software systems. These technology solutions include practice management software, data-driven applications, client communications tools, and related services.
Covetrus Inc
7 Custom House St
Portland MAINE 04101 US
CEO: Benjamin Wolin
Employees: 4035
Phone: 18882802221.0
Covetrus, Inc. is an animal-health technology and services company, which serves animal veterinary markets. The Company operates through three segments. North America segment offers supply chain services, software services and prescription management to its customers and animal-owners. Europe segment offers supply chain services and software services to its customers and animal-owners. Asia-Pacific & Emerging Markets segment offers supply chain services and software services to its customers and animal-owners. The Company's products and services include supply chain services, software services, and prescription management. It offers a comprehensive portfolio of products, services and value-added solutions for enhancing delivering animal care. It develops, provides and supports veterinary practices with a range of veterinary software systems. These technology solutions include practice management software, data-driven applications, client communications tools, and related services.
The current stock price of CVET is 20.99 USD. The price increased by 0.29% in the last trading session.
CVET does not pay a dividend.
CVET has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
CVET stock is listed on the Nasdaq exchange.
The PE ratio for Covetrus Inc (CVET) is 21.2. This is based on the reported non-GAAP earnings per share of 0.99 and the current share price of 20.99 USD.
The Revenue of Covetrus Inc (CVET) is expected to grow by 4.28% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ChartMill assigns a technical rating of 7 / 10 to CVET. When comparing the yearly performance of all stocks, CVET is one of the better performing stocks in the market, outperforming 88.09% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to CVET. CVET scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months CVET reported a non-GAAP Earnings per Share(EPS) of 0.99. The EPS increased by 4.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -0.28% | ||
| ROA | -0.38% | ||
| ROE | N/A | ||
| Debt/Equity | 0.65 |
11 analysts have analysed CVET and the average price target is 21.76 USD. This implies a price increase of 3.67% is expected in the next year compared to the current price of 20.99.
For the next year, analysts expect an EPS growth of 16.83% and a revenue growth 4.28% for CVET